Garrett Nichols

Chief Medical Officer, Chimerix (United States).

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jul 28, 2025Sold 937 shares at $6.98 of Candel Therapeutics³
Jul 28, 2025Exercised options 937 shares at $1.29 of Candel Therapeutics³
Jun 30, 2025Sold 781 shares at $5.04 of Candel Therapeutics⁴
Jun 30, 2025Exercised options 781 shares at $1.29 of Candel Therapeutics⁴
Mar 18, 2025Sold 45,316 shares at $8.76 of Candel Therapeutics⁵
Mar 18, 2025Exercised options 13,905 shares at $1.29 of Candel Therapeutics⁵
Mar 18, 2025Exercised options 4,584 shares at $3.75 of Candel Therapeutics⁵
Jan 15, 2025Sold 10,428 shares at $7.23 of Candel Therapeutics⁶
Jan 8, 2025Sold 10,799 shares at $8.22 of Candel Therapeutics⁷
Nov 29, 2024Sold 13,935 shares at $4.56 of Candel Therapeutics⁸
Jul 17, 2024Sold 10,875 shares at $6.47 of Candel Therapeutics⁹
Jul 11, 2024Sold 9,769 shares at $5.97 of Candel Therapeutics¹⁰
Nov 28, 2023Shares withheld for tax 12,175 shares at $0.90 of Candel Therapeutics¹¹
Nov 26, 2023Granted 88,822 shares of Candel Therapeutics¹²
Nov 28, 2022Granted 58,479 shares of Candel Therapeutics¹³

The numbers on this page point here. Each one links to the record it came from.